Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Obesity (Disorder) clinical trials
6 of 6 indexed Obesity (Disorder) trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 6 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Obesity (Disorder): 6 US clinical trials tracked, 6 recruiting.
Obesity (Disorder) is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. The most active sponsor is University of Oregon, running 1 of these trials.
Enrollment posture brief
Registry condition obesity-disorder
OPEN 6 | RECR 100% | LATE 0 | EARLY 0 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Obesity (Disorder) lists 6 open slots (100% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Obesity (Disorder) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Obesity (Disorder) is recruiting above its size-band peers.
6 of 6 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Obesity (Disorder) research.
University of Oregon accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Most Obesity (Disorder) trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 6 trials that report a genuine target (sentinel values excluded). 4 of those (66.7%) plan for fewer than 100 participants.
-
Obesity (Disorder) splits between interventional and observational designs.
3 interventional and 3 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity
Wake Forest University Health Sciences
NCT07227051
Healthy Living Anson Study
University of North Carolina, Chapel Hill
NCT07126587
The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity
University of Mississippi Medical Center
NCT07052539
Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy
University of South Carolina
NCT07313384
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)
Nemours Children's Clinic
NCT07169136
Repeated Far Infrared Sauna Bathing in Adults With Obesity
University of Oregon
NCT07158047
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Obesity (Disorder) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Obesity (Disorder) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Obesity (Disorder) page
6 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Obesity (Disorder) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Oregon sponsors the most Obesity (Disorder) trials on record, review their full trial history before evaluating a specific study. See University of Oregon's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Obesity (Disorder) condition card totals 6 registered trials; most-linked intervention GLP-1 Therapy; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.